Job Details
Senior Consultant Statistician / Director of Biostatistics – Early Phase Oncology
6851
Posted: 19/11/2026
- £Competitive
- Cheltenham, Gloucestershire, United Kingdom
- Contract
Senior Consultant Statistician / Director of Biostatistics – Early Phase Oncology
Location: UK or Europe – Remote
Contract Type: Flexible, Project-Based Consultancy
Hourly Rate: $100–$120 per hour, dependent on experience
Project Duration: Approximately 3–4 months per assignment
Estimated Commitment: 150 hours per project
Start Date: Early 2027, with potential for earlier engagement
The Opportunity
We are working with an expanding, specialist life sciences consultancy that provides advanced statistical and modelling expertise to pharmaceutical and biotechnology companies.
Due to increasing demand for its early-phase clinical development services, our client is looking to establish a network of highly experienced Consultant Statisticians / Director-level Biostatisticians to support innovative oncology clinical trial programmes.
This opportunity offers the flexibility of project-based consulting while providing exposure to scientifically challenging assignments, including first-in-human oncology studies, advanced Bayesian trial designs and regulatory strategy.
The successful consultants will play an important role in advising biotechnology clients on complex statistical methodologies, leading technical discussions and providing hands-on expertise throughout the study design process.
We are particularly interested in candidates who combine Director-level strategic expertise with strong practical statistical design capabilities.
Key Responsibilities
Early-Phase Clinical Development
We would welcome applications from:
Candidates do not necessarily need to hold a current Director title, provided they can demonstrate equivalent expertise, independence and technical leadership.
Contract Structure and Flexibility
These opportunities will be offered on a flexible, project-by-project consultancy basis.
Individual assignments are expected to involve approximately 150 hours over a 3–4 month period, although the distribution of hours may vary depending on project requirements.
Consultants may have the opportunity to work across multiple projects and establish a longer-term relationship with the consultancy as its client portfolio expands.
Candidates must be based in the UK or Europe and able to accommodate meetings with UK-based clients.
The anticipated start date is early 2027, although earlier availability would be welcomed for preliminary project and client discussions.
Why Consider This Opportunity?
If you are an experienced Director-level Biostatistician, Bayesian Statistician or Independent Statistical Consultant with strong early-phase oncology expertise, we would welcome a confidential discussion.
Please apply with your CV, availability and preferred hourly consulting rate to aimee@warmanobrien.com
We are also keen to connect with experienced consultants interested in future project-based opportunities.
Location: UK or Europe – Remote
Contract Type: Flexible, Project-Based Consultancy
Hourly Rate: $100–$120 per hour, dependent on experience
Project Duration: Approximately 3–4 months per assignment
Estimated Commitment: 150 hours per project
Start Date: Early 2027, with potential for earlier engagement
The Opportunity
We are working with an expanding, specialist life sciences consultancy that provides advanced statistical and modelling expertise to pharmaceutical and biotechnology companies.
Due to increasing demand for its early-phase clinical development services, our client is looking to establish a network of highly experienced Consultant Statisticians / Director-level Biostatisticians to support innovative oncology clinical trial programmes.
This opportunity offers the flexibility of project-based consulting while providing exposure to scientifically challenging assignments, including first-in-human oncology studies, advanced Bayesian trial designs and regulatory strategy.
The successful consultants will play an important role in advising biotechnology clients on complex statistical methodologies, leading technical discussions and providing hands-on expertise throughout the study design process.
We are particularly interested in candidates who combine Director-level strategic expertise with strong practical statistical design capabilities.
Key Responsibilities
- Lead the statistical design of early-phase oncology clinical trials, particularly Phase I and Phase I/II first-in-human studies.
- Provide expert advice on dose escalation, dose finding, dose optimisation and innovative trial design methodologies.
- Develop and implement advanced Bayesian and adaptive study designs, including BOIN and related methodologies.
- Lead technical discussions with biotechnology clients, presenting statistical recommendations and agreeing appropriate study designs.
- Act as a senior statistical adviser during client meetings and project discussions.
- Represent the statistical function in regulatory interactions, including FDA meetings.
- Contribute statistical expertise and supporting documentation for IND submissions.
- Perform or oversee simulations, statistical design evaluations and technical assessments.
- Work independently across multiple projects, collaborating with clinical development and scientific teams.
- Support early-stage client discussions and project proposals where specialist statistical expertise is required.
Early-Phase Clinical Development
- Extensive experience as a senior Biostatistician or Statistical Consultant within pharmaceutical, biotechnology or specialist clinical research environments.
- Strong expertise in early-phase oncology clinical trial design, particularly first-in-human studies.
- Demonstrable experience with dose-escalation and dose-finding methodologies.
- Practical experience with BOIN (Bayesian Optimal Interval) study designs.
- Knowledge of advanced BOIN variations, including BOIN-R, and relevant RELM methodologies.
- Strong understanding of Bayesian and adaptive trial design principles.
- Experience evaluating statistical operating characteristics and conducting design simulations.
- Familiarity with other model-based or model-assisted approaches would be advantageous.
- Experience supporting or leading statistical discussions with regulatory authorities, particularly the FDA.
- Previous involvement in IND submissions and statistical regulatory strategy.
- Strong communication skills, with the ability to explain and defend complex statistical methodologies.
- Proven ability to advise biotechnology clients and lead technical study design discussions.
- Confidence working autonomously as a senior statistical subject matter expert.
- Director-level statistical expertise, or equivalent senior consulting experience.
- Willingness to remain actively involved in hands-on statistical design work.
- Ability to balance technical delivery with strategic consultancy responsibilities.
- Strong problem-solving skills and a commercially aware, client-focused approach.
We would welcome applications from:
- Independent Biostatistics Consultants specialising in early-phase clinical development.
- Current or former Directors / Senior Directors of Biostatistics.
- Senior statistical experts from biotechnology companies, particularly those specialising in oncology.
- Experienced Bayesian trial design consultants.
- Senior CRO statisticians with significant early-phase study design, regulatory and client-facing experience.
Candidates do not necessarily need to hold a current Director title, provided they can demonstrate equivalent expertise, independence and technical leadership.
Contract Structure and Flexibility
These opportunities will be offered on a flexible, project-by-project consultancy basis.
Individual assignments are expected to involve approximately 150 hours over a 3–4 month period, although the distribution of hours may vary depending on project requirements.
Consultants may have the opportunity to work across multiple projects and establish a longer-term relationship with the consultancy as its client portfolio expands.
Candidates must be based in the UK or Europe and able to accommodate meetings with UK-based clients.
The anticipated start date is early 2027, although earlier availability would be welcomed for preliminary project and client discussions.
Why Consider This Opportunity?
- Work on innovative early-phase oncology clinical trials.
- Apply specialist Bayesian and adaptive design expertise to challenging clinical development programmes.
- Engage directly with biotechnology clients and influence important study design decisions.
- Combine strategic statistical consulting with hands-on technical work.
- Enjoy flexible, remote, project-based engagements.
- Potential to support multiple assignments and develop an ongoing consulting relationship.
- Join a growing network of specialist statistical experts supporting international clinical development programmes.
If you are an experienced Director-level Biostatistician, Bayesian Statistician or Independent Statistical Consultant with strong early-phase oncology expertise, we would welcome a confidential discussion.
Please apply with your CV, availability and preferred hourly consulting rate to aimee@warmanobrien.com
We are also keen to connect with experienced consultants interested in future project-based opportunities.
Aimee Weston
Principal Consultant in Biostatistics
Apply for this role
Recruitment